Nanoscope Therapeutics
Pre-clinicalNanoscope is focused on proprietary ambient light activated optogenetic therapy to restore vision in people suffering from all forms of Retinitis Pigmentosa, Stargardt and other inherited retinal degenerations as well as dry AMD.
Founded
2009
Focus
RNA & Gene TherapyViral Technology
About
Nanoscope is focused on proprietary ambient light activated optogenetic therapy to restore vision in people suffering from all forms of Retinitis Pigmentosa, Stargardt and other inherited retinal degenerations as well as dry AMD.
Funding History
3Total raised: $23.5M
Series B$15MUndisclosedMar 15, 2022
Series A$6MUndisclosedMay 15, 2020
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2009
LocationBedford, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile